# The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications

> **NCT00603148** · — · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 475 (estimated)

## Conditions studied

- Genetic Polymorphism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00603148
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 475 (ESTIMATED)
- **Last updated:** 2013-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603148, "The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00603148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*